Clinical Features Associated with Acute Elevated Intraocular Pressure After Intravitreal Anti-VEGF Injections

References

• GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e144–e160. doi:10.1016/S2214-109X(20)30489-7
   PubMed Web of Science ®Google Scholar
• Sun JK, Glassman AR, Beaulieu WT, et al. Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy. Ophthalmology. 2019;126(1):87–95. doi:10.1016/j.ophtha.2018.08.001
   PubMed Web of Science ®Google Scholar
• Gross JG, Glassman AR, Jampol LM, et al.; Writing Committee for the Diabetic Retinopathy Clinical Research Network. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: a Randomized Clinical Trial. JAMA. 2015;314(20):2137–2146. doi:10.1001/jama.2015.15217
   PubMed Web of Science ®Google Scholar
• Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615–625. doi:10.1016/j.ophtha.2011.01.031
   PubMed Web of Science ®Google Scholar
• Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye. 2013;27(7):787–794. doi:10.1038/eye.2013.107
   PubMed Web of Science ®Google Scholar
• Arikan G, Osman Saatci A, Hakan Oner F. Immediate intraocular pressure rise after intravitreal injection of ranibizumab and two doses of triamcinolone acetonide. Int J Ophthalmol. 2011;4(4):402–405. doi:10.3980/j.issn.2222-3959.2011.04.16
   PubMed Web of Science ®Google Scholar
• Gregori NZ, Weiss MJ, Goldhardt R, et al. Ocular decompression with cotton swabs lowers intraocular pressure elevation following intravitreal injection. J Glaucoma. 2014;23(8):508–512. doi:10.1097/IJG.0b013e318294865c
   PubMed Web of Science ®Google Scholar
• Falkenstein IA, Cheng L, Freeman WR. Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin). Retina. 2007;27(8):1044–1047. doi:10.1097/IAE.0b013e3180592ba6
   PubMed Web of Science ®Google Scholar
• Sharei V, Höhn F, Köhler T, Hattenbach LO, Mirshahi A. Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis). Eur J Ophthalmol. 2010;20(1):174–179. doi:10.1177/112067211002000124
   PubMed Web of Science ®Google Scholar
• Gismondi M, Salati C, Salvetat ML, Zeppieri M, Brusini P. Short-term effect of intravitreal injection of Ranibizumab (Lucentis) on intraocular pressure. J Glaucoma. 2009;18(9):658–661. doi:10.1097/IJG.0b013e31819c4893
   PubMed Web of Science ®Google Scholar
• Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol. 2007;42(6):807–811. doi:10.3129/i07-172
   PubMed Web of Science ®Google Scholar
• Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol. 2008;146(6):930–934.e1. doi:10.1016/j.ajo.2008.07.007
   PubMed Web of Science ®Google Scholar
• de Vries Victor A, Bassil FL, Ramdas Wishal D. The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis. Sci Rep. 2020;10:13248. doi:10.1038/s41598-020-70269-7
   PubMed Web of Science ®Google Scholar
• Foss AJE, Scott LJ, Rogers CA, et al. Changes in intraocular pressure in study and fellow eyes in the IVAN trial. Br J Ophthalmol. 2016;100(12):1662–1667. doi:10.1136/bjophthalmol-2015-307595
   PubMed Web of Science ®Google Scholar
• Good TJ, Kimura AE, Mandava N, Kahook MY. Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents. Br J Ophthalmol. 2011;95(8):1111–1114. doi:10.1136/bjo.2010.180729
   PubMed Web of Science ®Google Scholar
• Lam J, Luttrell I, Ding L, et al. Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection. Graefes Arch Clin Exp Ophthalmol. 2019;257(11):2489–2494. doi:10.1007/s00417-019-04431-x
   PubMed Web of Science ®Google Scholar
• Uyar E, Ulas F, Sahin S, Celebi S. Major factors affecting intraocular pressure spike after intravitreal ranibizumab injection: vitreous reflux and its amount. Eur J Ophthalmol. 2019;29(4):361–367. doi:10.1177/1120672119836613
   PubMed Web of Science ®Google Scholar
• Özkaya A, Alkin Z, Celik U, et al. Comparing the effects of three different intravitreal injection techniques on vitreous reflux and intraocular pressure. J Ocul Pharmacol Ther. 2013;29(3):325–329. doi:10.1089/jop.2012.0144
   PubMed Web of Science ®Google Scholar
• Salem WS, Zagora SL, Nguyen V, Mehta H, Gillies MC, Fraser-Bell S. Effect of intravitreal injection speed on acute rise in intraocular pressure. The SPEED IOP study. Clin Exp Ophthalmol. 2021;49(5):519–521. doi:10.1111/ceo.13934
   PubMed Web of Science ®Google Scholar
• Mathalone N, Arodi-Golan A, Sar S, et al. Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2012;250(10):1435–1440. doi:10.1007/s00417-012-1981-0
   PubMed Web of Science ®Google Scholar
• Karakurt Y, Ucak T, Taslı G, Agcayazı B, Icel E, Yılmaz H. The effects of intravitreal ranibizumab, aflibercept or dexamethasone implant injections on intraocular pressure changes. Med Sci Monit. 2018;24:9019–9025. doi:10.12659/MSM.910923
   PubMed Web of Science ®Google Scholar
• El Chehab H, Le Corre A, Agard E, Ract-Madoux G, Coste O, Dot C. Effect of topical pressure-lowering medication on prevention of intraocular pressure spikes after intravitreal injection. Eur J Ophthalmol. 2013;23(3):277–283. doi:10.5301/ejo.5000159
   PubMed Web of Science ®Google Scholar
• Ge J, Wand M, Chiang R, Paranhos A, Shields MB. Long-term effect of Nd:YAG laser posterior capsulotomy on intraocular pressure. Arch Ophthalmol. 2000;118(10):1334–1337. doi:10.1001/archopht.118.10.1334
   PubMedGoogle Scholar
• Martinez-de-la-Casa JM, Ruiz-Calvo A, Saenz-Frances F, et al. Retinal nerve fiber layer thickness changes in patients with age-related macular degeneration treated with intravitreal ranibizumab. Invest Ophthalmol Vis Sci. 2012;53(10):6214–6218. doi:10.1167/iovs.12-9875
   PubMed Web of Science ®Google Scholar
• Eadie BD, Etminan M, Carleton BC, Maberley DA, Mikelberg FS. Association of repeated intravitreous bevacizumab injections with risk for glaucoma surgery. JAMA Ophthalmol. 2017;135(4):363–368. doi:10.1001/jamaophthalmol.2017.0059
   PubMed Web of Science ®Google Scholar
• Cui QN, Gray IN, Yu Y, VanderBeek BL. Repeated intravitreal injections of anti-vascular endothelial growth factors and risk of intraocular pressure medication use. Graefes Arch Clin Exp Ophthalmol. 2019;257(9):1931–1939. doi:10.1007/s00417-019-04362-7
   PubMed Web of Science ®Google Scholar
• Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study | British Journal of Ophthalmology. Available from: https://bjo.bmj.com/content/98/11/1543. Accessed March 18, 2023.
   Google Scholar
• Gado AS, Macky TA. Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison. Clin Experiment Ophthalmol. 2014;42(7):650–655. doi:10.1111/ceo.12311
   PubMed Web of Science ®Google Scholar
• Hoguet A, Chen PP, Junk AK, et al. The effect of anti-vascular endothelial growth factor agents on intraocular pressure and glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology. 2019;126(4):611–622. doi:10.1016/j.ophtha.2018.11.019
   PubMed Web of Science ®Google Scholar
• Knip MM, Välimäki J. Effects of pegaptanib injections on intraocular pressure with and without anterior chamber paracentesis: a Prospective Study. Acta Ophthalmol. 2012;90(3):254–258. doi:10.1111/j.1755-3768.2010.01904.x
   PubMed Web of Science ®Google Scholar
• Theoulakis PE, Lepidas J, Petropoulos IK, Livieratou A, Brinkmann CK, Katsimpris JM. Effect of brimonidine/timolol fixed combination on preventing the short-term intraocular pressure increase after intravitreal injection of ranibizumab. Klin Monbl Augenheilkd. 2010;227(04):280–284. doi:10.1055/s-0029-1245201
   PubMedGoogle Scholar
• Carnota-Méndez P, Méndez-Vázquez C, Otero-Villar J, Saavedra-Pazos JA. Effect of Prophylactic Medication and Influence of Vitreous Reflux in Pressure Rise after Intravitreal Injections of Anti-VEGF Drugs. Eur J Ophthalmol. 2014;24(5):771–777. doi:10.5301/ejo.5000455
   PubMed Web of Science ®Google Scholar
• Soheilian M, Karimi S, Montahae T, Nikkhah H, Mosavi SA. Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study. Graefes Arch Clin Exp Ophthalmol. 2017;255(9):1705–1712. doi:10.1007/s00417-017-3702-1
   PubMed Web of Science ®Google Scholar